Multiple indirect pathway components

The term Multiple indirect pathway components refers to the collective set of neural structures and molecular elements that constitute the indirect pathway of the basal ganglia, a circuit primarily responsible for the inhibition of motor activity (Purves et al., 2001). This pathway involves a sequence of connections starting from the striatum (specifically D2 receptor-expressing neurons) to the external globus pallidus (GPe), followed by the subthalamic nucleus (STN), and finally to the internal globus pallidus (GPi) and substantia nigra pars reticulata (SNr) (Alexander & Crutcher, 1990). It acts as a functional counterbalance to the direct pathway; while the direct pathway facilitates movement, the indirect pathway suppresses it. In Parkinson's disease, the loss of dopaminergic modulation leads to an overactive indirect pathway, contributing to hallmark symptoms such as bradykinesia and rigidity (Missale et al., 1998). Conversely, underactivity or lesions within this circuit are associated with hyperkinetic disorders like Huntington's disease and hemiballismus. Pharmacological agents typically interact with this pathway by targeting specific receptors, most notably the dopamine D2 receptor, to restore the functional balance of the motor circuit. Because this entry describes a complex physiological circuit rather than a single molecular entity, it is classified as a pathway-level descriptor rather than a discrete therapeutic target.

Other names

Indirect pathway of the basal gangliaStriatopallidal pathwayD2-mediated motor circuitIndirect basal ganglia circuit

Modulation of the indirect basal ganglia circuit via dopamine D2 receptor signaling, GABAergic inhibition of the globus pallidus externa, and glutamatergic excitation of the output nuclei to regulate motor suppression.